Birdwatch Note Rating
2023-03-15 21:22:15 UTC - NOT_HELPFUL
Rated by Participant: E207AB42719C7CFAC54D4663CA53B33BD79A25F020A06A0B5D168C8C96CE6F03
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details